Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Ltd., a pioneer in non-radioactive diagnostic imaging technology for early cancer detection, is set to host a shareholder webinar to discuss resolutions for the upcoming EGM and provide updates on the MagSense imaging technology development. The event is an opportunity for shareholders to understand the company’s strategic direction and business milestones, as well as to engage with the leadership team in a Q&A session.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
